144 related articles for article (PubMed ID: 12531327)
1. Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems.
Glück R; Metcalfe IC
Vaccine; 2003 Jan; 21(7-8):611-5. PubMed ID: 12531327
[TBL] [Abstract][Full Text] [Related]
2. Influenza virosomes as an efficient system for adjuvanted vaccine delivery.
Glück R; Moser C; Metcalfe IC
Expert Opin Biol Ther; 2004 Jul; 4(7):1139-45. PubMed ID: 15268680
[TBL] [Abstract][Full Text] [Related]
3. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system.
Cryz SJ; Glück R
Dev Biol Stand; 1998; 92():219-23. PubMed ID: 9554278
[TBL] [Abstract][Full Text] [Related]
4. Influenza virosomes as a vaccine adjuvant and carrier system.
Moser C; Amacker M; Zurbriggen R
Expert Rev Vaccines; 2011 Apr; 10(4):437-46. PubMed ID: 21506642
[TBL] [Abstract][Full Text] [Related]
5. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
[TBL] [Abstract][Full Text] [Related]
6. The virosome concept for influenza vaccines.
Huckriede A; Bungener L; Stegmann T; Daemen T; Medema J; Palache AM; Wilschut J
Vaccine; 2005 Jul; 23 Suppl 1():S26-38. PubMed ID: 16026906
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.
de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A
Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs).
Glück R
Vaccine; 1999 Mar; 17(13-14):1782-7. PubMed ID: 10194840
[TBL] [Abstract][Full Text] [Related]
9. New technology platforms in the development of vaccines for the future.
Glück R; Metcalfe IC
Vaccine; 2002 Dec; 20 Suppl 5():B10-6. PubMed ID: 12477412
[TBL] [Abstract][Full Text] [Related]
10. Virosomal adjuvanted antigen delivery systems.
Moser C; Metcalfe IC; Viret JF
Expert Rev Vaccines; 2003 Apr; 2(2):189-96. PubMed ID: 12899570
[TBL] [Abstract][Full Text] [Related]
11. Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity.
Huckriede A; Bungener L; ter Veer W; Holtrop M; Daemen T; Palache AM; Wilschut J
Vaccine; 2003 Feb; 21(9-10):925-31. PubMed ID: 12547604
[No Abstract] [Full Text] [Related]
12. Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine.
Soema PC; Rosendahl Huber SK; Willems GJ; Jiskoot W; Kersten GF; Amorij JP
Pharm Res; 2015 Apr; 32(4):1505-15. PubMed ID: 25344321
[TBL] [Abstract][Full Text] [Related]
13. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.
Hunziker IP; Grabscheid B; Zurbriggen R; Glück R; Pichler WJ; Cerny A
Int Immunol; 2002 Jun; 14(6):615-26. PubMed ID: 12039913
[TBL] [Abstract][Full Text] [Related]
15. Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens.
Glück R
Vaccine; 1992; 10(13):915-9. PubMed ID: 1471412
[TBL] [Abstract][Full Text] [Related]
16. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R
Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863
[TBL] [Abstract][Full Text] [Related]
17. Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes.
Westerfeld N; Pluschke G; Zurbriggen R
Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):50-7. PubMed ID: 17131241
[TBL] [Abstract][Full Text] [Related]
18. Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.
Bungener L; Huckriede A; de Mare A; de Vries-Idema J; Wilschut J; Daemen T
Vaccine; 2005 Jan; 23(10):1232-41. PubMed ID: 15652665
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccines: the virosome concept.
Wilschut J
Immunol Lett; 2009 Feb; 122(2):118-21. PubMed ID: 19100779
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens.
Mallick AI; Kulkarni RR; St Paul M; Parvizi P; Nagy E; Behboudi S; Sharif S
Viral Immunol; 2012 Jun; 25(3):226-31. PubMed ID: 22512311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
